| Foldamers as versatile frameworks for the design and evolution of function CM Goodman, S Choi, S Shandler, WF DeGrado Nature chemical biology 3 (5), 252-262, 2007 | 942 | 2007 |
| Selective VIP receptor agonists facilitate immune transformation for dopaminergic neuroprotection in MPTP-intoxicated mice KE Olson, LM Kosloski-Bilek, KM Anderson, BJ Diggs, BE Clark, ... Journal of Neuroscience 35 (50), 16463-16478, 2015 | 83 | 2015 |
| Computational design of a β-peptide that targets transmembrane helices SJ Shandler, IV Korendovych, DT Moore, KB Smith-Dupont, CN Streu, ... Journal of the American Chemical Society 133 (32), 12378-12381, 2011 | 68 | 2011 |
| Development of a rotamer library for use in β-peptide foldamer computational design SJ Shandler, MV Shapovalov, RL Dunbrack, Jr, WF DeGrado Journal of the American Chemical Society 132 (21), 7312-7320, 2010 | 52 | 2010 |
| Infrared signature and folding dynamics of a helical β-peptide G Montalvo, MM Waegele, S Shandler, F Gai, WF DeGrado Journal of the American Chemical Society 132 (16), 5616-5618, 2010 | 46 | 2010 |
| Computational design of a self-assembling β-peptide oligomer IV Korendovych, YH Kim, AH Ryan, JD Lear, WF DeGrado, SJ Shandler Organic letters 12 (22), 5142-5145, 2010 | 42 | 2010 |
| A synthetic agonist to vasoactive intestinal peptide receptor-2 induces regulatory T cell neuroprotective activities in models of Parkinson’s disease RL Mosley, Y Lu, KE Olson, J Machhi, W Yan, KL Namminga, JR Smith, ... Frontiers in Cellular Neuroscience 13, 421, 2019 | 37 | 2019 |
| Highly active polypeptides and methods of making and using the same SJ Shandler, SH Gellman US Patent 9,782,454, 2017 | 26 | 2017 |
| Manganese-enhanced magnetic resonance imaging for detection of vasoactive intestinal peptide receptor 2 agonist therapy in a model of Parkinson's disease KE Olson, AN Bade, CR Schutt, J Dong, SJ Shandler, MD Boska, ... Neurotherapeutics 13 (3), 635-646, 2016 | 20 | 2016 |
| Environment- and Sequence-Dependence of Helical Type in Membrane-Spanning Peptides Composed of β3-Amino Acids IV Korendovych, SJ Shandler, GL Montalvo, WF DeGrado Organic letters 13 (13), 3474-3477, 2011 | 20 | 2011 |
| Compositions comprising glucagon analogs and methods of making and using the same S Shandler, SH Gellman US Patent 9,790,262, 2017 | 14 | 2017 |
| Peptides comprising non-natural amino acids and methods of making and using the same S Shandler, SH Gellman, JM Gledhill US Patent 9,789,164, 2017 | 4 | 2017 |
| Highly active polypeptides and methods of making and using the same SJ Shandler, SH Gellman US Patent 10,772,934, 2020 | 2 | 2020 |
| Peptides comprising non-natural amino acids and methods of making and using the same S Shandler, SH Gellman, JM Gledhill US Patent 11,278,595, 2022 | 1 | 2022 |
| NIH-PA Author Manuscript IV Korendovych, SJ Shandler, G Montalvo, WF DeGrado Org Lett 14 (12), 3236, 2012 | 1 | 2012 |
| Peptides comprising non-natural amino acids and methods of making and using the same S Shandler, SH Gellman, JM Gledhill US Patent App. 17/650,894, 2023 | | 2023 |
| Highly active polypeptides and methods of making and using the same SJ Shandler, SH Gellman US Patent App. 16/940,610, 2021 | | 2021 |
| Manganese-enhanced magnetic resonance imaging detects VIPR2-mediated immune transformation in a model of Parkinson’s disease KE Olson, C Schutt, A Bade, J Dong, M Boska, S Shandler, RL Mosley, ... The Journal of Immunology 196 (1_Supplement), 197.6-197.6, 2016 | | 2016 |
| Rational design and characterization of β-peptides, a non-natural peptidomimetic scaffold SJ Shandler University of Pennsylvania, 2009 | | 2009 |
